News

Reliv International’s GlucAffect, a nutritional supplement, seems to be effective in reducing blood glucose levels and control weight in study participants. The study included 50 overweight individuals who

Penwest has provided the results of its phase Ib clinical trial of A0001, for the treatment of mitochondrial diseases. The phase Ib trial was a single-blind, placebo-controlled, multiple

Biolex has provided the preclinical results demonstrating that the thrombolytic activity of the company’s full-length recombinant human plasmin (BLX-155), was superior to t-PA in a preclinical study. BLX-155

AstraZeneca and the Mental Health Research Institute in Australia have entered into a research collaboration agreement, to develop new ways of identifying Alzheimer’s disease patients at early stages

Ambrilia and Kotinos have signed a Patent and Technology Purchase agreement, whereby Kotinos will acquire Ambrilia’s prostate cancer therapeutic PCK3145 and related assets. Under the agreement, Ambrilia is

German Merck has received approval from Japanese Ministry of Health, Labor and Welfare to extend indication of Gonal-f (follitropin alfa for injection). It is for infertile women suffering

Zila has issued the following response to a complaint filed in the Delaware Court of Chancery by Intelident: “Zila is disappointed that Intelident is using a litigation strategy

Yara International has reported second-quarter net income of NOK1.12 billion, as compared to NOK4.35 billion last year. Excluding net foreign exchange gains and special items, the result was

Novartis has reported a 12% decrease in net income to $4 billion, for the first half of 2009. The decline was also impacted by financing costs incurred due